12th Annual Great Strides Together
The Great Strides Together is a continuing educational event well established in the state of Florida. This meeting includes CME/CE credits designed for oncology physicians, pharmacists, nurses, nurse practitioners, physician assistants, as well as other healthcare professionals involved in the management of cancer patients. Based on evaluations from the previous 11 consecutive years, this meeting has been able to deliver a state-of-the-art educational experience and hence, provide healthcare professionals with the tools to offer the best quality of care for their patients. The mission of the conference is to show value (improvement of patient outcomes) of utilizing APPs, Physicians, and RNs by presenting a comprehensive clinical, surgical, or other approached theme by providing education of a current treatment in oncology.
The overall theme of this conference is Team and how the physician and the support staff work together to provide the best care for the patient. When possible, we ask that the sessions be presented together with the physician, Advanced Provider Professional, and if possible a nurse. We believe it is important to include in each presentation how the physician and team work together and the benefits this provides to all.
We kindly ask that ALL attendees/industry/corporate members that wish to attend at any point during the meeting to register by clicking below.Register Now
The Following Companies are Supporting this Meeting with an Exhibit. Thank you:
Bristol Myers Squibb
MEETING NOTICE DOCUMENT FOR CORPORATE
FLASCO would like to invite your company to exhibit at this meeting.
EXHIBIT INFO: FLASCO is inviting you to exhibit. We are expecting 75-100 attendees at Great Strides Together. The cost is $1,000 for non-members to exhibit. FLASCO Corporate Members, please see the exhibit fee schedule below. We ask that you register to Exhibit by August 15, 2020.
CLICK HERE TO REGISTER: https://www.conftrac.com/flascoaug
Elite: Complimentary Exhibit
Diamond: Reduced exhibit Fee of $500
Platinum: Reduced exhibit Fee of $750
Gold: Reduced exhibit Fee of $850
All other Exhibitors: $1,000 Exhibit Fee
The following have registered to exhibit during this event. Thank you for supporting FLASCO events!
Bristol Myers Squibb
Continuing Education Information
Evaluation and Certificate of Attendance
In order to receive CME/CE/CPE credits for this program:
- A link to the evaluation will be emailed to you post-program. Please complete this within the allotted time frame.
- Your certificate of attendance will be emailed to you for download immediately after submission. Please keep this document in your files.
Accreditation and Credit Statements
In support of improving patient care, the Medical Educator Consortium is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician – The Medical Educator Consortium designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing – The Medical Educator Consortium designates this activity for 4.5 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. ONCC review is only for designating content to be used for ILNA points and is not for CNE accreditation. CNE programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing CE to be used for recertification by ONCC. If the CNE provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification or ILNA categories may be used in relation to the program.
Physician Assistant – The Medical Educator Consortium has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Disclosure Policy – The Medical Educator Consortium (MEC) adheres to the Joint Accreditation Criteria and ACCME Standards for Commercial Support, which requires everyone in a position of controlling the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests related to the activity content. MEC has implemented a mechanism to identify and resolve all conflicts of interest prior to the CME/CE activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity. CME/CE activities must be balanced, independent of commercial bias, and designed to improve quality in health care. All recommendations involving clinical medicine must be based on evidence within the medical profession.
Disclosure of Unlabeled Use – This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contradictions, and warnings.
Disclaimer – Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contradictions and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
GREAT STRIDES TOGETHER
Financial Toxicity of Cancer
CLL: New Indications and the Implications
Integrative/Complimentary Medicine Including Medical Marijuana
FLASCO: Why YOU Should Belong & What is the Role of the APP? Best Practices
Wellness and Burn-Out Prevention
Palliative Medicine: Maintaining Mental Health
A Precursor to the Hottest 2020 ASCO Annual Session Toxicity and Background on Cardio Oncology
Legislative Update & How YOU Can Advocate for Your Patient